[Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy].
T Yu DemidovaK G LobanovaS N PerekhodovM B AntsiferovO Sh OynotkinovaPublished in: Terapevticheskii arkhiv (2021)
A significant reduction in mortality among patients with COVID-19 was observed during therapy with ACEI/ARB, b-AB, and oral hypoglycemic therapy. Increased risk of death was associated with insulin therapy and diuretic therapy.